quality of the surgeries using a Likert rating scale from excellent to bad (1)(2)(3)(4)(5).
INTRODUCTION AND OBJECTIVES: Recurrent urethral stric-
tures following open urethral reconstruction can be challenging. We sought to determine the efficacy of salvage direct visualization internal urethrotomy (DVIU), and/or steroid injection in the post-urethroplasty setting, and to identify risk factors for subsequent failure.
METHODS: We identified all patients (n¼101) from two institutions who failed urethroplasty and underwent salvage DVIU. Triamcinolone (400mg) was injected intra-spongiosal in 86 patients at the time of the DVIU. The primary outcome of stricture recurrence was defined as need for an additional urethral procedure and inability to pass a 16 French flexible cystoscope. Baseline demographic and stricture characteristics for those with and without recurrence were compared using t-test, Chi square, and MannWhitney test where applicable. Univariable and multivariable logistic regression was performed to identify factors associated with salvage DVIU failure.
RESULTS: Median age at DVIU among all patients (n¼101) was 45.0 years (interquartile range [IQR] 35-57). Pre-urethroplasty stricture location was bulbar (n¼82, 81.1%), bulbo-membranous (n¼11, 10.9%), penile (n¼5, 5.0%), and panurethral (n¼3, 3.0%). Recurrent stricture length was 1.1 cm (mean). DVIU success rate was 68.3% with median follow-up of 44.5 months attempts, open surgery can be the last therapeutic option before urinary diversion. We present the extended follow-up of outcome and patient's satisfaction of the previously described T-plasty: A modified YV-plasty of the bladder neck in patients with highly recurrent BNS.
METHODS: In all, 30 patients who underwent T-plasty between December 2008 and July 2016 were retrospectively identified from our prospective urethroplasty data base. Patients were interviewed by telephone. Primary end point of was the treatment specific success rate defined as bladder neck patency without any history of recurrent stenosis or need of further intervention. Secondary endpoint was patient related outcome measurement.
RESULTS: Mean age was 68.3 yrs. (range 47-86), mean follow up was 44.9 months (range 2-92). As initial surgery for BPH, 83.3% of patients (n¼25) had a TURP, 10% had a HoLEP (n¼3) and 6.7% had a Greenlight-Laser (n¼2). Mean number of prior transurethral procedures to treat the BNS was 4.6 (range 1-19). Preoperatively mean Qmax was 6.8 ml/sec, mean post void residual volume was 141ml. Mean time of surgery was 111 min. (range 74-175). There was no relevant blood loss. No postoperative complications higher grad II according to Clavien-Dindo occurred. Mean time of hospital stay was 13.2 days (range 8-21). Success rate was 100%, one patient needed a permanent catheter due to acontractile detrusor. In one patient, preexisting stress incontinence increased. No de-novo stress incontinence occurred. In no patient further endoscopic or surgical treatment was needed. Postoperatively mean Qmax was 19.8 ml/sec, mean post void residual volume was 37ml. Both values were significantly improved compared to preoperative measurements (p¼0.019 and p¼0.01). In all 87.5% of patients were (very) satisfied. Only one patient was dissatisfied. In this patient preexisting stress incontinence increased postoperatively. Number of prior therapies did not correlate with patient's satisfaction.
CONCLUSIONS: The T-plasty represents a successful and safe procedure to treat highly recurrent BNS after surgery for BPH.
INTRODUCTION AND OBJECTIVES:
The gold standard treatment for severe post-prostatectomy incontinence is implantation of an artificial urinary sphincter (AUS). There is a paucity of data regarding the timing of AUS placement after prostatectomy and other factors which predict device failure.
METHODS: We identified all patients who underwent prostatectomy and subsequent AUS placement in SEER-Medicare from 2002-2011. These patients' demographic, clinical and pathologic characteristics were included in multivariable cox proportional hazard models, to identify predictors for device survival. We also analyzed factors impacting the time to revision or explantation from initial AUS implantation and prostatectomy.
RESULTS: 841 men underwent AUS placement at a median 23 months (IQR:15-40.6) after prostatectomy. 236 (28%) men ultimately required revision or explantation. There were no differences in age, race or hospital setting for those undergoing reoperation vs. not (p0.2). Patients who underwent reoperation were more likely to have had higher clinical stage cancer, undergone open prostatectomy, or had prior sling placement (p<0.01). There were no differences in rates of diabetes, smoking status, prior radiation therapy, or Charlson Comorbidity Index scores between those requiring reoperation vs. not (all p >0.15). Patients with delayed AUS placement (29%), defined as >3 years after prostatectomy, experienced prolonged device survival (Figure) . Delayed patients were significantly more likely to have received radiation therapy [36.5% vs. 10.5% (p<0.001)]. Nonetheless, delayed repair was confirmed to be protective on multivariate analysis, after controlling for patient and disease characteristics including radiation history [HR:0.44 CONCLUSIONS: Delayed AUS implantation in the Medicare population is associated with prolonged device survival, while radiation exposure and prior urethral sling surgery predict for early reoperation. Further work is required to identify patient specific factors which may explain variability in timing for AUS after prostatectomy and how such factors contribute to device longevity.
Source of Funding: None

MP36-19 DE NOVO PENILE DEVIATION AFTER URETHROPLASTY WIRH ORAL MUCOSA: A RELEVANT PROBLEM?
Abhishek Pandey*, Cristina Raita, Joern Beier, Hansj€ org Keller, Hof, Germany INTRODUCTION AND OBJECTIVES: There are no reliable data about the incidence of de novo Penisschaftdeviation (PD) after urethral reconstruction using oral mucosa graft(OMG). We evaluated 700 patients who underwent a urethroplasty using OMG.
METHODS: Of 800 operated patients between 04/1994 and 08/ 2013 700 were evaluated with a minimum follow up of 12 (12-205) months using a standardized questionnaire. All patients received a ventral onlay. We investigated the occurrence of de novo Deviation. In case of a de novo PD we asked about the impairment in sexual intercourse and whether the patient wants counselling and treatment. All patients who answered any of these questions with yes, were contacted once again telephonically.
RESULTS: 442 (63.1%). 8.5% (38) answered with yes to at least one of the questions. The mean stricture length was 10.2 cm (2-25); 94.5% (36/38) could be contacted by phone again. 47.3% (18/38) had misinterpreted the question or had a PD preoperatively. 13.1% (5/ 38) had a preoperative Erectile dysfunction with a median IIEF-5 score of 5. Thus remaining 39.4% (15/38) with a de novo PD, i.e. 3.3% of the total population. Consultation request was 1.1% (5/442). 8/15 (53.3%) with de novo PD (stricture length 13-21) had a slight deviation laterally, 3/15 (20%) dorsally and 2/15 (13.3%) a deviation anteriorly. 2 patients could not be contacted. None of these patients wanted treatment or had problems with sexual intercourse. CONCLUSIONS: A de novo PD after urethroplasty with OMG occurs in 3.3%. The deviation is minimal and does not imply a desire for treatment, respectively impairment in sexual intercourse. These are the first data collected in a large population about the occurrence of PD after urethral reconstruction with OMG.
Source of Funding: None
MP36-20 OUTCOMES OF STAGED URETHROPLASTY IN THE MANAGEMENT OF URETHRAL STRICTURES RELATED TO HYPOSPADIAS
Shree Agrawal*, Amanda Chi, Kenneth Angermeier, Hadley Wood, Cleveland, OH INTRODUCTION AND OBJECTIVES: Urethral stricture disease related to hypospadias in adults can be challenging surgical problem due to poor quality and paucity of local tissue for repair. We report our experience with staged urethroplasty using buccal mucosal graft in this population.
METHODS: Patients who underwent the first of staged urethroplasty using oral mucosa for hypospadias related strictures between 2002 and 2014 at our tertiary referral center were retrospectively reviewed. Patient characteristics, past surgical history, and surgical details were assessed with outcomes, which included complications, revisions, and voiding without obstructive symptoms. Statistical analysis was completed using univariable and multivariable logistic regression models and the Kaplan-Meier method.
RESULTS: Fifty-one patients were identified, with a median follow-up of 17 months (IQR 7-59); 50 patients completed all stages of repair. Median age at the time of first stage urethroplasty was 36 years . A majority of patients had penile (38, 75%) or panurethral (12, 24%) strictures. Twenty-four (47%) of patients had subcoronal location of meatus prior to surgery. Following staged repair, 19 (37%) patients and 18 (35%) had subcoronal or orthotopic location of the meatus. Less than half patients (23, 45%) received previous endoscopic procedures. A total of 44 (87%) patients had undergone previous open repair, among these patients, 21 had ¼2 prior repairs. Median length of buccal mucosal graft, used in all first stage repairs was 7 cm (IQR: 6-10). At 6 months, the complication
